ANDREA RABADI: Open Payments
NPI 1700228301 · PLAINFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,198 in 143 payments from 22 companies in 2025. Trend: 2023 $2,889 · 2024 $2,397 · 2025 $2,198
Food & beverage: $2,198
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 19 | $411 |
| Supernus Pharmaceuticals, Inc. | 33 | $356 |
| Otsuka America Pharmaceutical, Inc. | 20 | $316 |
| Corium, LLC | 15 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $174 |
| Neos Therapeutics, LP | 9 | $141 |
| Vanda Pharmaceuticals Inc. | 4 | $84 |
| HARMONY BIOSCIENCES LLC | 2 | $75 |
| Alkermes, Inc. | 3 | $69 |
| Lundbeck LLC | 3 | $66 |
Products named: Auvelity, Qelbree, REXULTI, Azstarys, CAPLYTA, Adzenys XR-ODT, HETLIOZ, WAKIX.
Industry payments across IN — which companies pay providers there.
